While there is no cure for multiple myeloma, increased awareness about the symptoms can be the key to timely diagnosis and ...

Several studies have been conducted, but questions remain about where such therapies will fit into multiple myeloma treatment ...

For decades, the diagnosis of multiple myeloma required evidence of end-organ damage characterized by myeloma-defining events ...

What Is Refractory Multiple Myeloma? Multiple myeloma is a cancer that affects a type of white blood cell called a plasma cell, which helps your immune system fight infections. Refractory means ...

British biotech CellCentric is settling into a new office in Boston, part of the company’s expansion into the U.S. as ...

Elotuzumab binds to a cell surface protein, called SLAMF7, which is found on myeloma cells and on a type of immune cell known as the natural killer (NK) cell.

Multiple myeloma is a kind of blood cancer that starts in plasma cells. Inside most of your bones is a soft, spongy tissue called bone marrow. Here, your body makes hundreds of thousands of red ...

A: Doxorubicin; C: Cytoxan; CR: Complete remission; CyBorD: Cyclophosphamide, bortezomib and dexamethasone; D: Dexamethasone; nCR: Near complete remission; PLD ...

Forty-eight patients with multiple myeloma, most of them ambulatory outpatients, at 5 co-operating hospitals,‡ were treated. Patients were entered in the double-blind study by randomized card ...

Monoclonal gammopathy of undetermined significance (MGUS) is not cancer. There’s a small risk it can become cancer. Out of every 100 people with MGUS, each year, 1 or 2 of them will get cancer from ...

All patients were eligible for assessment of improvement of renal function. Based on the criteria recently proposed by Ludwig et al, renal complete response (CRrenal) was defined as sustained (ie ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Multiple ...